当前位置: 首页 > 详情页

STI571 protects neuronal cells from neurotoxic prion protein fragment-induced apoptosis

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [a]Department of Veterinary Pathology, College of Animal Sciences, Henan Institute of Science and Technology, Xinxiang, China [b]State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong-Da Street, Fengtai District, Beijing 100071, China [c]Department of Neurosurgery, Xuanwu Hospital, Capital Medical University, 45Chang-Chun Street, Xicheng District, Beijing 100053, China
出处:
ISSN:

关键词: c-Abl tyrosine kinase Imatinib mesylate Neuronal death Prion diseases PrP106-126

摘要:
Prion diseases are neurodegenerative disorders caused by the accumulation of misfolded prion proteins [scrapie form of PrPSc (PrPSc)]. PrPsc accumulation in the brain causes neurotoxicity by inducing mitochondrial-apoptotic pathways. Neurodegeneration can be prevented by imatinib mesylate (Gleevec or STI571) that regulates c-Abl tyrosine kinases, which elicit protective effects in neurodegenerative disease models. However, the protective effect of STI571 against prion disease remains unknown. In the present study, the effect of STI571 on prion peptide-induced neuronal death was investigated. Results showed that STI571 rescued neurons from PrP106-126-induced neurotoxicity by preventing mitochondria] dysfunction. STI571-inhibited c-Abl tyrosine kinases prevented PrP106-126-induced reduction in mitochondria] potential, Bax translocation to the mitochondria and cytochrome c release. The protective effect of STI571 against mitochondrial dysfunction was related to the activation of BIM expression. This study is the first to demonstrate the protective effect of STI571 against prion-mediated neurotoxicity. Our results suggested that imatinib mesylate treatment may be a novel therapeutic strategy to treat prion-mediated neurotoxicity. (C) 2015 Elsevier Ltd. All rights reserved.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2014]版:
大类 | 2 区 医学
小类 | 2 区 神经科学 2 区 药学
最新[2025]版:
大类 | 2 区 医学
小类 | 2 区 药学 3 区 神经科学
JCR分区:
出版当年[2013]版:
Q1 NEUROSCIENCES Q1 PHARMACOLOGY & PHARMACY
最新[2024]版:
Q1 NEUROSCIENCES Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2024版] 最新五年平均 出版当年[2013版] 出版当年五年平均 出版前一年[2012版] 出版后一年[2014版]

第一作者:
第一作者机构: [a]Department of Veterinary Pathology, College of Animal Sciences, Henan Institute of Science and Technology, Xinxiang, China
共同第一作者:
通讯作者:
通讯机构: [b]State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, 20 Dong-Da Street, Fengtai District, Beijing 100071, China [*1]Department of Veterinary Pathology, College of Animal Sciences, Henan Institute of Science and Technology, Xinxiang 453003, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:18261 今日访问量:1 总访问量:1003 更新日期:2025-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 首都医科大学宣武医院 技术支持:重庆聚合科技有限公司 地址:北京市西城区长椿街45号宣武医院